Antiphospholipid antibodies and antithrombin deficiency: Double trouble for pregnancy

American Journal of Hematology

Volumn 86, Issue 12, 2011, Pages 1028-1031

  Kujovich, Jody ^a   Merrill, Patrick A ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b LEGACY EMANUEL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOLIPIN ANTIBODY; ENOXAPARIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY;

ADULT; ANTICOAGULATION; ANTITHROMBIN DEFICIENCY; ARTICLE; CASE REPORT; DEEP VEIN THROMBOSIS; FEMALE; HELLP SYNDROME; HUMAN; INTRAUTERINE GROWTH RETARDATION; LEG THROMBOSIS; LIVER FUNCTION TEST; LOW DRUG DOSE; MEDICAL ABORTION; PARTIAL THROMBOPLASTIN TIME; PLACENTA CIRCULATION; PREGNANCY; PRIORITY JOURNAL;

ABORTION, HABITUAL; ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; ANTITHROMBIN III; ANTITHROMBIN III DEFICIENCY; FAMILY HEALTH; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; VENOUS THROMBOSIS;

EID: 81355148752     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22157     Document Type: Article

References (26)

1. Rai R, Regan L. Recurrent miscarriage. Lancet 2006; 368: 601-611.
2. Sabadell J, Casellas M, Alijotas-Reig J, et al. Inherited antithrombin deficiency and pregnancy: Maternal and fetal outcomes. Eur J Obstet Gynecol Reprod Biol 2010; 149: 47-51.
3. Folkeringa N, Brouwer JL, Korteweg FJ, et al. Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women. Br J Haematol. 2007; 136: 656-661.
4. Preston FE, Rosendaal FR, Walker ID, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996; 348: 913-916.
5. Bates SM, Greer IA, Pabinger I, et al. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133(6 Suppl): 844S-886S.
6. Practice bulletin no. 113: Inherited thrombophilias in pregnancy. Obstet gynecol 2010; 116: 212-222.
7. Maclean PS, Tait RC. Hereditary and acquired antithrombin deficiency: Epidemiology, pathogenesis and treatment options. Drugs 2007; 67: 1429-1440.
8. Khor B, Van Cott EM. Laboratory tests for antithrombin deficiency. Am J Hematol 2010; 85: 947-950.
9. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
10. Mak A, Cheung MW, Cheak AA, Ho RC. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: A meta-analysis of randomized controlled trials and meta-regression. Rheumatology 2010; 49: 281-288.
11. Gris JC. LMWH have no place in recurrent pregnancy loss: Debate-against the motion. Thromb Res 2011; 127(Suppl 3): S110-S112.
12. Hansen JB, Sandset PM. Differential effects of low molecular weight heparin and unfractionated heparin on circulating levels of antithrombin and tissue factor pathway inhibitor (TFPI): A possible mechanism for difference in therapeutic efficacy. Thromb Res. 1998; 91: 177-181.
13. Morikawa M, Yamada T, Kataoka S, et al. Changes in antithrombin activity and platelet counts in the late stage of twin and triplet pregnancies. Semin Thromb Hemost 2005; 31: 290-296.
14. Kobayashi T, Terao T, Ikenoue T, et al. Treatment of severe preeclampsia with antithrombin concentrate: Results of a prospective feasibility study. Semin Thromb Hemost 2003; 29: 645-652.
15. Tincani A, Bazzani C, Zingarelli S, Lojacono A. Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: Clinical characteristics, diagnosis, pathogenesis, and treatment. Semin Thromb Hemost. 2008; 34: 267-273.
16. Dogan OO, Simsek Y, Celen S, Danisman N. Frequency of hereditary thrombophilia, anticoagulant activity, and homocysteine levels in patients with hemolysis, elevated liver functions and low thrombocyte count (HELLP) syndrome. J Obstet Gynaecol Res 2011; 37: 527-533.
17. Ruffatti A, Tonello M, Del Ross T, et al. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost 2006; 96: 337-341.
18. Ruffatti A, Tonello M, Cavazzana A, et al. Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy. Thromb Res 2009; 123: 482-487.
19. Ruffatti A, Calligaro A, Hoxha A, et al. Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome. Arthritis Care Res 2010; 62: 302-307.
20. Tiede A, Tait RC, Shaffer DW, et al. Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations. Thromb Haemost 2008; 99: 616-622.
21. Rodgers GM. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update. Thromb Haemost 2009; 101: 806-812.
22. Schwartz RS, Bauer KA, Rosenberg RD, et al. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group. Am J Med 1989; 87: 53S-60S.
23. Yamada T, Yamada H, Morikawa M, et al. Management of pregnancy with congenital antithrombin III deficiency: Two case reports and a review of the literature. J Obstet Gynaecol Res 2001; 27: 189-197.
24. Abrahams VM. Mechanisms of antiphospholipid antibody-associated pregnancy complications. Thromb Res 2009; 124: 521-525.
25. Szilagyi A, Nagy A, Tamas P, et al. Two successful pregnancies following eight miscarriages in a patient with antithrombin deficiency. Gynecol Obstet Invest. 2006; 61: 111-114.
26. Maki M, Kobayashi T, Terao T, et al. Antithrombin therapy for severe preeclampsia: Results of a double-blind, randomized, placebo-controlled trial. BI51.017 Study Group. Thromb Haemost. 2000; 84: 583-590.